相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019
Boghuma K. Titanji et al.
CLINICAL INFECTIOUS DISEASES (2021)
Inflammasome formation in the lungs of patients with fatal COVID-19
Stefano Toldo et al.
INFLAMMATION RESEARCH (2021)
Infliximab and Intravenous Gammaglobulin in Hospitalized Severe COVID-19 Patients in Intensive Care Unit
Mohsen Farrokhpour et al.
ARCHIVES OF IRANIAN MEDICINE (2021)
The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
William Damsky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Coronavirus infections and immune responses
Geng Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
COVID-19: combining antiviral and anti-inflammatory treatments
Justin Stebbing et al.
LANCET INFECTIOUS DISEASES (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Emergence of a novel human coronavirus threatening human health
Leo L. M. Poon et al.
NATURE MEDICINE (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The COVID-19 epidemic
Thirumalaisamy P. Velavan et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2020)
Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
Abinit Saha et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
Omer Gendelman et al.
AUTOIMMUNITY REVIEWS (2020)
COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
Theoharis C. Theoharides
BIOFACTORS (2020)
Colchicine may not be effective in COVID-19 infection; it may even be harmful?
Medine Cumhur Cure et al.
CLINICAL RHEUMATOLOGY (2020)
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Francesca Coperchini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis
Ka Shing Cheung et al.
GASTROENTEROLOGY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
David S. Fedson et al.
mBio (2020)
The effects of statins on dental and oral health: a review of preclinical and clinical studies
Shabnam Tahamtan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Management of acute kidney injury in patients with COVID-19
Claudio Ronco et al.
LANCET RESPIRATORY MEDICINE (2020)
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Yonggang Zhou et al.
NATIONAL SCIENCE REVIEW (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Statin therapy in COVID-19 infection
Vincenzo Castiglione et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
COVID-19: Clean up on IL-6
Tanner L. Hedrick et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Type 1 interferons as a potential treatment against COVID-19
Erwan Sallard et al.
ANTIVIRAL RESEARCH (2020)
Emerging pharmacotherapies for COVID-19
Rachana Salvi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Dexamethasone caution
S. I. Morganstein et al.
BRITISH DENTAL JOURNAL (2020)
The protein expression profile of ACE2 in human tissues
Feria Hikmet et al.
MOLECULAR SYSTEMS BIOLOGY (2020)
Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment
Swamy Yeleswaram et al.
CLINICAL IMMUNOLOGY (2020)
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients
Reed B. Hogan et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2020)
COVID-19: Review on latest available drugs and therapies against SARS- CoV-2. Coagulation and inflammation cross-talking
Giuseppe Magro
VIRUS RESEARCH (2020)
Clinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed
Konrad Kleszczynski et al.
NUTRIENTS (2020)
Immunotherapeutic approaches to curtail COVID-19
Hajar Owji et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection
Stephanie Pons et al.
CRITICAL CARE (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Melatonin Synthesis and Function: Evolutionary History in Animals and Plants
Dake Zhao et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Management of cytokine release syndrome related to CAR-T cell therapy
Hongli Chen et al.
FRONTIERS OF MEDICINE (2019)
The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease
Jung Goo Lee et al.
BRAIN SCIENCES (2019)
Medical Treatment of Nasal Airway Obstruction
Daniel R. Cox et al.
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA (2018)
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
Amber J. Giles et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Role of Histamine in Modulating the Immune Response and Inflammation
Anna Claudia Calvielli Castelo Branco et al.
MEDIATORS OF INFLAMMATION (2018)
Redox Biology of Respiratory Viral Infections
Olga A. Khomich et al.
VIRUSES-BASEL (2018)
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Simon A. Jones et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in PatientsWith Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA
Hisham Abdallah et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Severe hypertriglyceridemia and colchicine intoxication following suicide attempt
Shaul Lev et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway
Nicola Raftery et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Melatonin: Pharmacology, Functions and Therapeutic Benefits
Sylvie Tordjman et al.
CURRENT NEUROPHARMACOLOGY (2017)
IL-6 Trans-Signaling Drives Murine Crescentic GN
Gerald S. Braun et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
A pilot, non-randomized evaluation of the safety of anakinra plus FOLFIRINOX in metastatic pancreatic ductal adenocarcinoma patients.
Andrew Whiteley et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection
Rahul Vijay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Atorvastatin attenuates myocardial remodeling induced by chronic intermittent hypoxia in rats: Partly involvement of TLR-4/MYD88 pathway
Xiao Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia
Simone M. C. Spoorenberg et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
The pharmacology of statins
Cesare R. Sirtori
PHARMACOLOGICAL RESEARCH (2014)
Locally injected Infliximab ameliorates murine DSS colitis: Differences in serum and intestinal levels of drug between healthy and colitic mice
Loris Riccardo Lopetuso et al.
DIGESTIVE AND LIVER DISEASE (2013)
Control of Myofibroblast Differentiation by Microtubule Dynamics through a Regulated Localization of mDia2
Nathan Sandbo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Higher-dose Anakinra Is Effective in a Case of Medically Refractory Macrophage Activation Syndrome
Philip J. Kahn et al.
JOURNAL OF RHEUMATOLOGY (2013)
T lymphocytes as a target of histamine action
Tomasz Kmiecik et al.
ARCHIVES OF MEDICAL SCIENCE (2012)
IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
Stefan Rose-John
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults
Nalaka S. Gooneratne et al.
JOURNAL OF PINEAL RESEARCH (2012)
MECHANISMS OF DISEASE Purinergic Signaling during Inflammation
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Single dose oral dexamethasone versus multi-dose prednisolone in the treatment of acute exacerbations of asthma in children who attend the emergency department: study protocol for a randomized controlled trial
John Cronin et al.
TRIALS (2012)
Regulatory T Cells in Arterivirus and Coronavirus Infections: Do They Protect Against Disease or Enhance it?
Thomas E. Cecere et al.
VIRUSES-BASEL (2012)
Enhanced Bioavailability of Atorvastatin Calcium from Stabilized Gastric Resident Formulation
Furquan Nazimuddin Khan et al.
AAPS PHARMSCITECH (2011)
Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
Toshio Tanaka et al.
FEBS LETTERS (2011)
Outcomes After Rigid Bronchoscopy in Children With Suspected or Confirmed Foreign Body Aspiration: A Retrospective Study
Madan Mohan Maddali et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2011)
Anti-TNF therapies: a comprehensive analysis of adverse effects associated with immunosuppression
Victoria Connor
RHEUMATOLOGY INTERNATIONAL (2011)
Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
Ron J. Keizer et al.
CLINICAL PHARMACOKINETICS (2010)
Colchicine poisoning: the dark side of an ancient drug
Yaron Finkelstein et al.
CLINICAL TOXICOLOGY (2010)
Tocilizumab for the treatment of rheumatoid arthritis
Toshio Tanaka et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug Naproxen
Kelsey C. Duggan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Chemotherapeutic Agents Targeting the Tubulin Cytoskeleton Modify LPS-induced Cytokine Secretion by Dendritic Cells and Increase Antigen Presentation
Viviana Marin-Esteban et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal
Khoury
Drug Design Development and Therapy (2010)
Long-term melatonin administration protects brain mitochondria from aging
Miguel Carretero et al.
JOURNAL OF PINEAL RESEARCH (2009)
Anakinra for Rheumatoid Arthritis: A Systematic Review
Marty Mertens et al.
JOURNAL OF RHEUMATOLOGY (2009)
IFN-beta-mediated inhibition of IL-8 expression requires the ISGF3 components Stat1, Stat2, and IRF-9
Travis Laver et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2008)
Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation
George Nuki
Current Rheumatology Reports (2008)
IFN-β protects from vascular leakage via up-regulation of CD73
Jan Kiss et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Human pharmacology of naproxen sodium
Marta L. Capone et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Colchicine promotes antigen cross-presentation by murine dendritic cells
Norikatsu Mizumoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?
Dun-Xian Tan et al.
JOURNAL OF PINEAL RESEARCH (2007)
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor α inhibitor infliximab
Klaus Bendtzen et al.
ARTHRITIS AND RHEUMATISM (2006)
Discovery of novel immunostimulants by dendritic-cell-based functional screening
N Mizumoto et al.
BLOOD (2005)
Anakinra: Review of recombinant human interieukin-1 receptor antagonist in the treatment of rheumatoid arthritis
DE Furst
CLINICAL THERAPEUTICS (2004)
Risk factors for adverse events in analgesic drug users:: results from the PAIN study
N Moore et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2003)
Pharmacokinetics of anakinra in subjects with different levels of renal function
BB Yang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Pharmacologic characteristics of statins
JM McKenney
CLINICAL CARDIOLOGY (2003)
Clinical pharmacokinetics of atorvastatin
H Lennernas
CLINICAL PHARMACOKINETICS (2003)
Quality of life in multiple sclerosis:: influence of interferon-β1a (Avonex®) treatment
P Vermersch et al.
MULTIPLE SCLEROSIS JOURNAL (2002)
Receptor-mediated pharmacokinetic/pharmacodynamic model of interferon-β 1a in humans
DE Mager et al.
PHARMACEUTICAL RESEARCH (2002)
Colchicine decreases apoptotic cell death in chronic cyclosporine nephrotoxicity
C Li et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2002)
The interferon antiviral response: from viral invasion to evasion
N Grandvaux et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2002)
The immunotherapeutic potential of melatonin
GJM Maestroni
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis
MH Schiff
ANNALS OF THE RHEUMATIC DISEASES (2000)
Pharmacokinetics and pharmacodynamics of IFN-β1a in healthy volunteers
PA Buchwalder et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2000)
The absolute bioavailability of oral melatonin
RL DeMuro et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Topical colchicine therapy for actinic keratoses
M Grimaitre et al.
DERMATOLOGY (2000)
分享论文
